"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESDesign your trials around patients as well as products. With tools to measure, analyze and improve patient experience in trials, support regulatory approval and differentiate your drug for payers.
The 2016 21st Century Cures Act in the United States reinforced the importance of patient centricity in healthcare research and mandated the FDA’s Patient Focused Drug Development program. Guidance documents subsequently issued by the FDA clarify the expectations of Sponsors to measure and report the patient perspective on the benefits and risks of new interventions.
Similarly, since about 2020 the European Medicines Agency has been encouraging Sponsors to engage in patient-focused medicines development, and to specifically collect patient experience data regarding aspects of disease management that are important for patients. They too have offered guidance on collecting and sharing data for benefit-risk decision-making.
IQVIA can help you meet the expectations of FDA and EMA and make the patient experience a meaningful measure of therapeutic value.
Our solutions are designed to dovetail with existing internal capabilities, so from strategy development to regulator and payer communications, you have what you need to amplify the patient perspective.
Widespread use of mobile devises is bringing patients closer to trials than ever before, from enabling remote recruitment to giving patients an "always on" way to report information about symptoms and quality of life.
IQVIA's e-Clinical Outcome Assessment (eCOA) seamlessly integrates self-reported data from patients into the overall endpoints reporting process. So internal and external stakeholders can seamlessly extract insights from traditional and digital data.
Beyond meeting regulatory and payer asks, taking patient feedback into account can change the way your trials work, and the quality of your outcomes. Listening to patients can give you a different point of view on what constitutes better treatment. So you can design trials that respond to what patients value, and get to better treatments faster.
That in turn can support significant differentiation and attendant advantages, both in gaining market access, achieving regulatory acceptance and finding the highest and best applications for your therapy.
As an increasingly important cornerstone in successful intervention development, patient experience data (PED) can help developers make decisions about which interventions will most likely meet unmet needs and live up to the promise of maximizing health and well-being.
Our team of experts are specialists in PED. Our recently published book – Using Patient Experience Data to Evaluate Medical Interventions – provides a robust overview of how PED can be generated during intervention development, and how it can be utilized to inform decision-making at the regulatory, payer, healthcare professional and patient levels. Contact us to learn how to apply these principles in your product development.
To learn more, download chapter 1, “Patient experience data (PED) in intervention development – what is it, why should you care, and how can this book help?”
Access new resources for advanced therapy development, from candidate identification through market authorization.
